Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with...
43 insider purchases on record · latest filing 2026-06-02.
Insiders have also filed 82 sale transactions at AUPH.